Description

5-amino-1mq ™

5-amino-1mq ™ is a small‑molecule NNMT inhibitor studied for its role in fat metabolism, NAD+ elevation, and metabolic health. Unlike peptides such as AOD9604™ or Cerebrolysin™, 5‑Amino‑1MQ™ is a synthetic compound but often grouped with peptide therapies in longevity and weight‑loss research.

 What Is Neuro Labs 5‑Amino‑1MQ™?

5‑Amino‑1MQ™ is a quinolinium derivative:

• Inhibits nicotinamide N‑methyltransferase (NNMT).
• Preserves nicotinamide for NAD+ biosynthesis.
• Increases SAM (S‑adenosylmethionine) levels.
• Activates sirtuins (SIRT1, SIRT3) for mitochondrial health.

5-amino-1mq ™ Key Features

• NNMT inhibition.
• NAD+ elevation.
• Fat metabolism.
• Mitochondrial biogenesis.
• Longevity research.

 How Does 5‑Amino‑1MQ™ Work?

• Blocks NNMT enzyme activity → prevents nicotinamide loss.
• Boosts NAD+ levels → enhances energy metabolism.
• Activates sirtuins → supports DNA repair and mitochondrial function.
• Reduces fat cell maturation → lowers PPAR‑γ expression.
• Promotes browning of fat tissue → increases thermogenesis.

 Benefits of 5‑Amino‑1MQ™

5‑Amino‑1MQ™ is studied as a nicotinamide N‑methyltransferase (NNMT) inhibitor with promising effects on fat metabolism, NAD+ elevation, and metabolic health. While still experimental, here are the key benefits highlighted in preclinical research:

🩺 Clinical & Research Benefits

• Fat loss: Reduces adiposity by preventing fat cell maturation and promoting fat breakdown.
• NAD+ elevation: Preserves nicotinamide for NAD+ biosynthesis, supporting longevity pathways.
• Metabolic health: Improves insulin sensitivity and energy expenditure in preclinical models.
• Muscle preservation: Helps maintain lean mass during caloric restriction.
• Mitochondrial biogenesis: Activates sirtuins (SIRT1, SIRT3) to enhance mitochondrial function.

 Lifestyle & Wellness Benefits

• Weight management: Supports fat metabolism and body composition goals.
• Energy boost: Enhances ATP production through improved mitochondrial efficiency.
• Healthy aging: Promotes resilience by supporting NAD+ and sirtuin activity.
• Cognitive support: Potential indirect benefits via NAD+ pathways and mitochondrial health.

📊 Summary Table

The 5‑Amino‑1MQ™ compound offers dual benefits in fat metabolism and NAD+ elevation, making it a unique candidate in longevity and metabolic research. By inhibiting NNMT, it not only reduces fat accumulation but also enhances NAD+ availability, fueling sirtuin activity and mitochondrial health.

Lifestyle & Wellness Benefits

• Energy boost: Supports mitochondrial ATP production.
• Healthy aging: Enhances resilience and vitality.
• Weight management: Promotes fat metabolism.

📊 Comparison – 5‑Amino‑1MQ™ vs Other Compounds

⚠️ Risks & Considerations

• Preclinical only: No human clinical trials yet.
• Safety profile: Rodent studies show no hepatotoxicity, but human data is lacking.
• Availability: Research‑grade compound, not FDA‑approved.
• Mislabeling risk: Sometimes marketed as a “peptide,” but it is a small molecule.

❓ Frequently Asked Questions

• Is 5‑Amino‑1MQ™ a peptide? → No, it is a small‑molecule NNMT inhibitor.
• Does 5‑Amino‑1MQ™ boost NAD+? → Yes, by preserving nicotinamide for NAD+ biosynthesis.
• Is it safe? → Preclinical data suggests safety in rodents, but human safety is unproven.
• Is it available for sale? → Only as a research compound, not approved for medical use.

📌 Long Conclusion

The 5‑Amino‑1MQ™ compound is a novel NNMT inhibitor with potential in fat loss, NAD+ elevation, and metabolic health. Unlike peptides such as AOD9604™ or NAD+ precursors (NMN, NR), it directly modulates enzymatic pathways at the intersection of energy metabolism and epigenetics.

Its ability to reduce fat mass, preserve lean tissue, and elevate NAD+ makes it a promising candidate in longevity and metabolic research. However, with no human clinical trials yet, it remains an experimental compound limited to research contexts.